United Therapeutics chairperson and CEO Martine A. Rothblatt reports sale of $4.33 million in common shares

UTHR•2026-11-06

United Therapeutics CEO Martine A. Rothblatt sold 7,540 common shares on Nov. 5, 2026, and exercised options for 9,500 shares at $117.76 each. The transactions left affected trust holdings at 326,403 shares and her directly owned holdings at 40,513 shares.

United Therapeutics chairperson and CEO Martine A. Rothblatt reports sale of $4.33 million in common shares

1. Share transactions

Related News

Verra Mobility former CFO Craig C. Conti reports disposal of $20,074.182 in common shares

SI-BONE CFO Anshul Maheshwari reports sale of $81,175 in common shares

ICE President Benjamin Jackson sells common shares worth $1.35 million

Sources

United Therapeutics chairperson and CEO Martine A. Rothblatt reports sale of $4.33 million in common shares

Tactile Systems Technology grants COO Stephen Kiewiet 6,438 restricted stock units

Fractyl Health appoints Michael Wartell as independent director